PAHC official logo PAHC
PAHC 4-star rating from Upturn Advisory
Phibro Animal Health Corporation (PAHC) company logo

Phibro Animal Health Corporation (PAHC)

Phibro Animal Health Corporation (PAHC) 4-star rating from Upturn Advisory
$40.4
Last Close (24-hour delay)
upturn advisory logo
PASS
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

12/16/2025: PAHC (4-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

Upturn 4 star rating for performance

Above Average Performance

These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.

Number of Analysts

1 star rating from financial analysts

4 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $43

1 Year Target Price $43

Analysts Price Target For last 52 week
$43 Target price
52w Low $15.98
Current$40.4
52w High $46.29

Analysis of Past Performance

Type Stock
Historic Profit 88.13%
Avg. Invested days 49
Today’s Advisory PASS
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 4.0
Stock Returns Performance Upturn Returns Performance icon 4.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 12/16/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 1.64B USD
Price to earnings Ratio 24.19
1Y Target Price 43
Price to earnings Ratio 24.19
1Y Target Price 43
Volume (30-day avg) 4
Beta 0.77
52 Weeks Range 15.98 - 46.29
Updated Date 12/16/2025
52 Weeks Range 15.98 - 46.29
Updated Date 12/16/2025
Dividends yield (FY) 1.18%
Basic EPS (TTM) 1.67

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 4.84%
Operating Margin (TTM) 13.42%

Management Effectiveness

Return on Assets (TTM) 8.55%
Return on Equity (TTM) 23.79%

Valuation

Trailing PE 24.19
Forward PE 10.57
Enterprise Value 2348327836
Price to Sales(TTM) 1.17
Enterprise Value 2348327836
Price to Sales(TTM) 1.17
Enterprise Value to Revenue 1.68
Enterprise Value to EBITDA 12.98
Shares Outstanding 20447574
Shares Floating 20291124
Shares Outstanding 20447574
Shares Floating 20291124
Percent Insiders 0.76
Percent Institutions 99.86

About Phibro Animal Health Corporation

Exchange NASDAQ
Headquaters Teaneck, NJ, United States
IPO Launch date 2014-04-11
Chairman, President & CEO Mr. Jack Clifford Bendheim
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Full time employees 2475
Full time employees 2475

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.